http://news.gambro.com/ Mynewsdesk RSS - Press Releases, News, and Blog Posts. http://news.gambro.com/ http://www.mynewsdesk.com/images/redesign/graphics/logos/logo-small.png 128 23 en 15 Thu, 03 May 2012 12:32:28 +0100 Gambro is the number one provider globally in high-quality water purification for dialysis. With the launch of the new Central Water Plant (CWP) 106 H Double Pump (DP) we extend the product offering to our customers by providing a unit with a higher product water flow at 45L/ min with inbuilt redundancy. http://news.gambro.com/news/view/gambro-introduces-the-central-water-plant-106-h-dp-a-new-benchmark-in-water-purification-for-dialysis-39823?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/gambro-introduces-the-central-water-plant-106-h-dp-a-new-benchmark-in-water-purification-for-dialysis-39823?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Mon, 16 Apr 2012 09:00:00 +0100 Gambro introduces SelectBag® Citrate to improve quality of life for hemodialysis patients. Improving quality of life for hemodialysis patients is a primary goal of the innovative new SelectBag® Citrate concentrate from Gambro — the unique citrate-containing, acetate-free dialysis fluid for regular hemodialysis and hemodiafiltration treatment. http://news.gambro.com/pressrelease/view/gambro-introduces-selectbag-r-citrate-to-improve-quality-of-life-for-hemodialysis-patients-750749?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-introduces-selectbag-r-citrate-to-improve-quality-of-life-for-hemodialysis-patients-750749?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Mon, 06 Feb 2012 09:01:00 +0000 A research consortium headed by Gambro in Germany, consisting of researchers from different disciplines, has received a project grant of 2.1 million euros from the German Federal Ministry of Education and Research. The project aims to investigate a new generation of dialysis membranes to improve the treatment of chronic inflammation in End Stage Renal Disease patients. http://news.gambro.com/pressrelease/view/bmbf-funds-a-research-project-coordinated-by-gambro-to-investigate-chronic-inflammation-in-esrd-patients-729924?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/bmbf-funds-a-research-project-coordinated-by-gambro-to-investigate-chronic-inflammation-in-esrd-patients-729924?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Mon, 21 Nov 2011 10:11:03 +0000 Dominique Janbon has been appointed CFO of Gambro effective Feb 1, 2012. He will succeed Jan Roxendal, currently interim CFO of Gambro. http://news.gambro.com/news/view/dominique-janbon-appointed-new-cfo-of-gambro-31678?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/dominique-janbon-appointed-new-cfo-of-gambro-31678?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Mon, 07 Nov 2011 11:00:00 +0000 The Gambro team will be at ASN Kidney Week 2011 in Philadephia, USA, November 10-12. As a global medical technology company and a leader in extracorporeal therapies, we will have many exciting discussions taking place in and outside of the exhibit hall. http://news.gambro.com/news/view/meet-gambro-at-asn-2011-in-philadelphia-30904?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/meet-gambro-at-asn-2011-in-philadelphia-30904?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Thu, 06 Oct 2011 13:12:00 +0100 Effective CRRT is largely determined by adequate anticoagulation of the extracorporeal circuit. With FleXitrate, Gambro makes performing regional citrate anticoagulation simple and safe. http://news.gambro.com/pressrelease/view/gambro-introduces-flexitrate-the-complete-citrate-calcium-offering-for-continuous-renal-replacement-therapy-crrt-690807?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-introduces-flexitrate-the-complete-citrate-calcium-offering-for-continuous-renal-replacement-therapy-crrt-690807?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Fri, 23 Sep 2011 08:57:00 +0100 Gambro invites you to stop by our exhibit at the 24th European Society of Intensive Care Medicine, and learn more about FleXitrate – our latest enhancement to CRRT with Prismaflex. http://news.gambro.com/news/view/meet-gambro-at-esicm-2011-in-berlin-28239?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/meet-gambro-at-esicm-2011-in-berlin-28239?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Mon, 22 Aug 2011 10:00:00 +0100 Jan Roxendal has been appointed interim CFO of Gambro effective September 1, 2011. He will replace Marika Fredriksson, currently CFO and Senior Vice President Finance of Gambro who has decided to leave Gambro. http://news.gambro.com/news/view/jan-roxendal-appointed-new-interim-cfo-of-gambro-26627?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/jan-roxendal-appointed-new-interim-cfo-of-gambro-26627?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Thu, 11 Aug 2011 19:00:00 +0100 Dr. Guido Oelkers has been appointed President and CEO of Gambro and is expected to join Gambro no later than Nov. 1, 2011. He will succeed Ulf Mattsson, currently interim President and CEO who will continue his assignment as a member of the Board of Directors. http://news.gambro.com/news/view/dr-guido-oelkers-appointed-new-president-and-ceo-of-gambro-26269?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/dr-guido-oelkers-appointed-new-president-and-ceo-of-gambro-26269?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Fri, 15 Jul 2011 10:00:00 +0100 It all started in 1984, with the production of single lumen catheters. Today, more than 70 employees work at Gambro Kathetertechnik in Hechingen, which recently celebrated 25 years of catheter production. http://news.gambro.com/pressrelease/view/gambro-celebrates-25-years-of-catheter-development-in-its-manufacturing-plant-in-hechingen-germany-661799?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-celebrates-25-years-of-catheter-development-in-its-manufacturing-plant-in-hechingen-germany-661799?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Tue, 05 Jul 2011 10:00:00 +0100 On June 24, 2011, Gambro hosted a Lunch Symposium at the ERA-EDTA Congress in Prague which attracted great interest from the Congress delegates. The main topic discussed was different therapy options for individualized quality-assured dialysis. http://news.gambro.com/pressrelease/view/gambro-industry-symposium-therapy-options-for-individualized-quality-assured-dialysis-at-the-era-edta-congress-in-prague-658745?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-industry-symposium-therapy-options-for-individualized-quality-assured-dialysis-at-the-era-edta-congress-in-prague-658745?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Wed, 08 Jun 2011 16:47:00 +0100 On June 1st, Gambro signed an agreement with Italian Trade Union representatives at the Italian Ministry of Economic Development (Ministero dello Sviluppo Economico) to continue with the optimization of the bloodline manufacturing foot print as announced on January 27, 2011. http://news.gambro.com/pressrelease/view/gambro-signs-agreement-with-italian-trade-unions-to-optimize-the-bloodline-manufacturing-in-medolla-italy-654304?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-signs-agreement-with-italian-trade-unions-to-optimize-the-bloodline-manufacturing-in-medolla-italy-654304?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Mon, 23 May 2011 16:48:00 +0100 As part of the ongoing work to make Gambro more efficient and cost effective, a decision has been made to move the Gambro headquarters from Stockholm to Lund, Sweden. http://news.gambro.com/pressrelease/view/gambro-headquarters-moves-from-stockholm-to-lund-sweden-654306?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-headquarters-moves-from-stockholm-to-lund-sweden-654306?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Thu, 28 Apr 2011 16:40:00 +0100 http://news.gambro.com/news/view/new-study-applies-economic-model-to-calculate-cost-benefits-of-gambro-s-theralite-membrane-for-use-on-myeloma-kidney-patients-24512?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/new-study-applies-economic-model-to-calculate-cost-benefits-of-gambro-s-theralite-membrane-for-use-on-myeloma-kidney-patients-24512?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Wed, 06 Apr 2011 16:37:00 +0100 Gambro is donating 10M Japanese Yen, equivalent of app. 720 000 SEK, to the Japanese Red Cross as part of its continued support to the people of Japan during this time of crisis. http://news.gambro.com/pressrelease/view/gambro-makes-monetary-donation-to-the-red-cross-in-japan-654299?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-makes-monetary-donation-to-the-red-cross-in-japan-654299?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Mon, 07 Mar 2011 12:45:00 +0000 International Symposium on Intensive Care and Emergency Medicine http://news.gambro.com/news/view/welcome-to-the-31st-isicem-20280?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/welcome-to-the-31st-isicem-20280?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Thu, 24 Feb 2011 12:48:00 +0000 On February 23, Gambro entered into the world of social media, with the launch of corporate profiles on three popular websites. http://news.gambro.com/news/view/gambro-launches-social-media-profiles-20281?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/gambro-launches-social-media-profiles-20281?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Thu, 27 Jan 2011 12:51:00 +0000 Gambro today announces its decision to cease bloodline manufacturing in Medolla, Italy, in order to optimize its global bloodline manufacturing footprint. The company has decided to outsource a number of the bloodline manufacturing activities currently performed at the site, and to consolidate the remaining bloodline activities into its manufacturing sites in Přerov, Shanghai and Tijuana. http://news.gambro.com/pressrelease/view/gambro-optimizes-its-global-bloodline-manufacturing-footprint-611003?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-optimizes-its-global-bloodline-manufacturing-footprint-611003?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Tue, 18 Jan 2011 12:56:00 +0000 Ulf Mattsson has today been appointed as the new Interim President and CEO of Gambro. He is currently a Board Member and will succeed Thomas Glanzmann who has stepped down from the position he has held since December 2006. http://news.gambro.com/news/view/ulf-mattsson-appointed-new-interim-president-and-ceo-of-gambro-20282?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/news/view/ulf-mattsson-appointed-new-interim-president-and-ceo-of-gambro-20282?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB Mon, 27 Dec 2010 12:57:00 +0000 Gambro today announced it has finalized* the sale of its global peritoneal dialysis (PD) business to Fresenius Medical Care. The ownership of Gambro’s solutions manufacturing plant in Canosa, Italy will coincide with the transfer of the manufacturing license expected to occur in early 2011. http://news.gambro.com/pressrelease/view/gambro-finalizes-the-sale-of-its-global-pd-business-to-fresenius-medical-care-611009?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://news.gambro.com/pressrelease/view/gambro-finalizes-the-sale-of-its-global-pd-business-to-fresenius-medical-care-611009?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Gambro AB